AACR 2026: Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies
A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and…
Browsing: ovarian cancer
“Electronic nose” may help identify ovarian cancer signatures from blood samples
A machine-learning–enabled “electronic nose” capable of identifying ovarian cancer–associated signatures from blood plasma samples has…
Women warned menopause can mask ovarian cancer
Matter doctors are warning women that the onset of menopause and perimenopause can sometimes mask…
Overall survival benefit with elenagen plus gemcitabine in platinum-resistant ovarian cancer
Dr. Gabriel Levin, gynaecologic oncologist at the McGill University Health Centre, and Director of Oncology…
Lung cancer drug offers a surprising new treatment against ovarian cancer
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor…
National genomic screening program would save thousands of Australians from preventable cancer and heart disease
Leading genomic health experts from Monash University are calling for urgent government funding to progress…
When ovarian cancer alters the abdominal cavity
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients,…
Cannabis derivatives could provide new ovarian cancer treatments
In the future, scientists could use drugs made from cannabis to target ovarian cancer. A…
Potential new treatment for aggressive ovarian cancer
Scientists at The University of Texas, USA, have found a promising new target in the…
Australian researchers uncover new driver of ovarian cancer spread
Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that…